Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese - PubMed (original) (raw)
Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese
A L Mooyaart et al. Diabetes Res Clin Pract. 2009 Sep.
Abstract
We investigated the frequency of the 5/5 homozygous CNDP1 (carnosinase) genotype, which was found to be associated with a reduced risk of developing diabetic nephropathy, in three ethnic groups in The Netherlands. Particularly interesting were the South Asian Surinamese, who have a high prevalence of diabetic nephropathy. Furthermore, we investigated the association between this gene and carnosinase activity in South Asian Surinamese and whether carnosinase was expressed in the kidney. We genotyped 290 South Asian Surinamese, 532 African Surinamese, and 472 White Dutch in a cross-sectional population study. Furthermore, an independent cohort of South Asian Surinamese was genotyped. In this population, carnosinase activity was measured in serum. Immunostaining and in situ hybridization for CNDP1 were performed on kidney tissue. Both South Asian populations had lower frequencies of the 5/5 homozygous genotype than African Surinamese and White Dutch (23.0%, 27.2%, 38.2%, and 41.3%, respectively; chi-square, p<0.001). This genotype showed a lower carnosinase activity in South Asian Surinamese (Wilcoxon rank-sum, p=0.03). CNDP1 was expressed in the kidney. South Asian Surinamese have a lower frequency of the 5/5 homozygous genotype, which was associated with lower carnosinase activity. Our study provides an indication that South Asian Surinamese are genetically at risk for developing diabetic nephropathy.
Similar articles
- A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells.
Riedl E, Koeppel H, Brinkkoetter P, Sternik P, Steinbeisser H, Sauerhoefer S, Janssen B, van der Woude FJ, Yard BA. Riedl E, et al. Diabetes. 2007 Sep;56(9):2410-3. doi: 10.2337/db07-0128. Epub 2007 Jun 29. Diabetes. 2007. PMID: 17601991 - A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.
Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Xu J, McDonough C, Janssen B, Yard BA, van der Woude FJ, Bowden DW. Freedman BI, et al. Nephrol Dial Transplant. 2007 Apr;22(4):1131-5. doi: 10.1093/ndt/gfl717. Epub 2007 Jan 5. Nephrol Dial Transplant. 2007. PMID: 17205963 Clinical Trial. - Association between CNDP1 genotype and diabetic nephropathy is sex specific.
Mooyaart AL, Zutinic A, Bakker SJ, Grootendorst DC, Kleefstra N, van Valkengoed IG, Böhringer S, Bilo HJ, Dekker FW, Bruijn JA, Navis G, Janssen B, Baelde HJ, De Heer E. Mooyaart AL, et al. Diabetes. 2010 Jun;59(6):1555-9. doi: 10.2337/db09-1377. Epub 2010 Mar 23. Diabetes. 2010. PMID: 20332346 Free PMC article. - [Carnosine, carnosinase and kidney diseases].
Kiliś-Pstrusińska K. Kiliś-Pstrusińska K. Postepy Hig Med Dosw (Online). 2012 Apr 20;66:215-21. doi: 10.5604/17322693.991600. Postepy Hig Med Dosw (Online). 2012. PMID: 22706107 Review. Polish. - Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.
Peters V, Zschocke J, Schmitt CP. Peters V, et al. J Inherit Metab Dis. 2018 Jan;41(1):39-47. doi: 10.1007/s10545-017-0099-2. Epub 2017 Oct 13. J Inherit Metab Dis. 2018. PMID: 29027595 Review.
Cited by
- Intrinsic carnosine metabolism in the human kidney.
Peters V, Klessens CQ, Baelde HJ, Singler B, Veraar KA, Zutinic A, Drozak J, Zschocke J, Schmitt CP, de Heer E. Peters V, et al. Amino Acids. 2015 Dec;47(12):2541-50. doi: 10.1007/s00726-015-2045-7. Epub 2015 Jul 24. Amino Acids. 2015. PMID: 26206726 Free PMC article. - CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia.
Yahya MJ, Ismail PB, Nordin NB, Akim ABM, Binti Md Yusuf WS, Adam NLB, Zulkifli NF. Yahya MJ, et al. J Nutr Metab. 2019 Jan 3;2019:8736215. doi: 10.1155/2019/8736215. eCollection 2019. J Nutr Metab. 2019. PMID: 30719346 Free PMC article. - The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes.
Kurashige M, Imamura M, Araki S, Suzuki D, Babazono T, Uzu T, Umezono T, Toyoda M, Kawai K, Imanishi M, Hanaoka K, Maegawa H, Uchigata Y, Hosoya T, Maeda S. Kurashige M, et al. PLoS One. 2013;8(1):e54064. doi: 10.1371/journal.pone.0054064. Epub 2013 Jan 16. PLoS One. 2013. PMID: 23342076 Free PMC article. - State of the Art in the Development of Human Serum Carnosinase Inhibitors.
Regazzoni L. Regazzoni L. Molecules. 2024 May 24;29(11):2488. doi: 10.3390/molecules29112488. Molecules. 2024. PMID: 38893364 Free PMC article. Review. - Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease.
Rodriguez-Niño A, Hauske SJ, Herold A, Qiu J, van den Born J, Bakker SJL, Krämer BK, Yard BA. Rodriguez-Niño A, et al. J Diabetes Res. 2019 Dec 24;2019:6850628. doi: 10.1155/2019/6850628. eCollection 2019. J Diabetes Res. 2019. PMID: 31950064 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous